PIPA5113255
TBC1D22A Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5113255-Each-of-1 | In Stock | ₹ 43,120.50 |
PIPA5113255 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 43,120.50
GST (18%): ₹ 7,761.69
Total Price: ₹ 50,882.19
Antigen
TBC1D22A
Classification
Polyclonal
Conjugate
Unconjugated
Gene
TBC1D22A
Gene Alias
BC023106; C22orf4; D15Ertd781e; HSC79E021; putative GTPase activator; RGD1306588; TBC1 domain family member 22A; TBC1 domain family, member 22a; TBC1D22A
Host Species
Rabbit
Purification Method
Protein G
Regulatory Status
RUO
Gene ID (Entrez)
25771, 689443
Content And Storage
-20°C or -80°C if preferred
Form
Liquid
Applications
ELISA, Western Blot
Concentration
4.5 mg/mL
Formulation
PBS with 50% glycerol and 0.03% ProClin 300; pH 7.4
Gene Accession No.
Q8WUA7
Gene Symbols
TBC1D22A
Immunogen
Recombinant Human TBC1 domain family member 22A protein (1-280AA)
Quantity
100 μg
Primary or Secondary
Primary
Target Species
Human, Rat
Product Type
Antibody
Isotype
IgG
Related Products
Description
- TBC1D22A (TBC1 domain family, member 22A), also known as C22orf4, is a 517 amino acid protein that contains one Rab-GAP TBC domain and is thought to function as a GTPase-activating protein for Rab family members
- Multiple isoforms of TBC1D22A exist due to alternative splicing events
- The gene encoding TBC1D22A maps to human chromosome 22, which houses over 500 genes and is the second smallest human chromosome
- Mutations in several of the genes that map to chromosome 22 are involved in the development of Phelan-McDermid syndrome, neurofibromatosis type 2, autism and schizophrenia
- Additionally, translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia chromosome and the subsequent production of the novel fusion protein BCR-Abl, a potent cell proliferation activator found in several types of leukemias.